Skip to main content

Silver Nanoparticle as an Effective Antiviral Agent

  • Chapter
  • First Online:
Polymer Nanocomposites Based on Silver Nanoparticles

Part of the book series: Engineering Materials ((ENG.MAT.))

Abstract

The infections from viral pathogens pose a significant global health challenge. The emergence of viral strains resistant to conventional antiviruses and the adverse side effects due to their prolonged use slow down the application of many antiviral therapies. The silver nanoparticles are considered a potentially useful tool for preventing various pathogens. The silver nanoparticles have already proven its potential as an efficient antiviral agent offered by their unique physical and chemical properties. The silver nanoparticles provide an excellent opportunity for novel antiviral therapies as it can attack a broad range of viruses with a lower possibility for developing resistant antiviral strains compared to conventional antiviral drugs. This chapter discusses the application of silver nanoparticles as an efficient antiviral agent against human immunodeficiency virus, respiratory syncytial virus, hepatitis B virus, monkeypox virus. Furthermore, the effect of silver nanoparticles against coronaviruses and the development of silver nanoparticles on their application as an effective antiviral therapeutic agent against pathogenic viruses have been discussed in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Aftab, S., Kurbanoglu, S., Ozcelikay, G., Bakirhan, N.K., Shah, A., Ozkan, S.A.: Carbon quantum dots co-catalyzed with multiwalled carbon nanotubes and silver nanoparticles modified nanosensor for the electrochemical assay of anti-HIV drug Rilpivirine. Sensor. Actuat. B Chem. 285, 571–583 (2019). https://doi.org/10.1016/j.snb.2019.01.094

    Article  CAS  Google Scholar 

  • Baram-Pinto, D., Shukla, S., Perkas, N., Gedanken, A., Sarid, R.: Inhibition of herpes simplex virus type 1 infection by silver nanoparticles capped with mercaptoethane sulfonate. Bioconjug. Chem. 20, 1497–1502 (2009). https://doi.org/10.1021/bc900215b

    Article  CAS  Google Scholar 

  • Chen, Y.N., Hsueh, Y.H., Hsieh, C. Te, Tzou, D.Y., Chang, P.L.: Antiviral activity of graphene–silver nanocomposites against non-enveloped and enveloped viruses. Int. J. Environ. Res. Public Health 13, 4–6 (2016). https://doi.org/10.3390/ijerph13040430

  • Du, T., Zhang, J., Li, C., Song, T., Li, P., Liu, J., Du, X., Wang, S.: Gold/Silver hybrid nanoparticles with enduring inhibition of coronavirus multiplication through multisite mechanisms. Bioconjug. Chem (2020). https://doi.org/10.1021/acs.bioconjchem.0c00506

  • Elechiguerra, J.L., Burt, J.L., Morones, J.R., Camacho-Bragado, A., Gao, X., Lara, H.H., Yacaman, M.J.: Interaction of silver nanoparticles with HIV-1. J. Nanobiotechnol. 3, 1–10 (2005). https://doi.org/10.1186/1477-3155-3-6

    Article  Google Scholar 

  • Galdiero, S., Falanga, A., Vitiello, M., Cantisani, M., Marra, V., Galdiero, M.: Silver nanoparticles as potential antiviral agents. Molecules 16, 8894–8918 (2011). https://doi.org/10.3390/molecules16108894

  • Jeremiah, S.S., Miyakawa, K., Morita, T., Yamaoka, Y.: Potent antiviral effect of silver nanoparticles on SARS-CoV-2. 533, 195–200 (2020). https://doi.org/10.1016/j.bbrc.2020.09.018

  • Kumar, S.D., Singaravelu, G., Ajithkumar, S., Murugan, K., Nicoletti, M., Benelli, G.: Mangrove-mediated green synthesis of silver nanoparticles with high HIV-1 reverse transcriptase inhibitory potential. J. Clust. Sci. 28, 359–367 (2017). https://doi.org/10.1007/s10876-016-1100-1

    Article  CAS  Google Scholar 

  • Lara, H.H., Ayala-Nuñez, N.V., Ixtepan-Turrent, L., Rodriguez-Padilla, C.: Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnol. 8, 1–10 (2010a). https://doi.org/10.1186/1477-3155-8-1

    Article  CAS  Google Scholar 

  • Lara, H.H., Ixtepan-Turrent, L., Garza-Treviño, E.N., Rodriguez-Padilla, C.: PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture. J. Nanobiotechnology 8, 1–11 (2010b). https://doi.org/10.1186/1477-3155-8-15

  • Li, Y., Lin, Z., Zhao, M., Guo, M., Xu, T., Wang, C., Xia, H., Zhu, B.: Reversal of H1N1 influenza virus-induced apoptosis by silver nanoparticles functionalized with amantadine. RSC Adv. 6, 89679–89686 (2016a). https://doi.org/10.1039/c6ra18493f

  • Li, Y., Lin, Z., Zhao, M., Xu, T., Wang, C., Hua, L., Wang, H., Xia, H., Zhu, B.: Silver nanoparticle based codelivery of oseltamivir to inhibit the activity of the H1N1 influenza virus through ROS-mediated signaling pathways. ACS Appl. Mater. Interfaces 8, 24385–24393 (2016b). https://doi.org/10.1021/acsami.6b06613

  • Lu, L., Sun, R.W., Chen, R., Hui, C., Ho, C., Luk, J.M., Lau, G.K.K.: Original article silver nanoparticles inhibit hepatitis B virus. Antivir. Ther. 13, 253–262 (2007)

    Google Scholar 

  • Mohammed Fayaz, A., Ao, Z., Girilal, M., Chen, L., Xiao, X., Kalaichelvan, P.T., Yao, X.: Inactivation of microbial infectiousness by silver nanoparticles-coated condom: A new approach to inhibit HIV- and HSV-transmitted infection. Int. J. Nanomedicine 7, 5007–5018 (2012). https://doi.org/10.2147/IJN.S34973

  • Morris, D., Ansar, M., Speshock, J., Ivanciuc, T., Qu, Y., Casola, A., Garofalo, R.: Antiviral and immunomodulatory activity of silver nanoparticles in experimental rsv infection. Viruses 11, (2019). https://doi.org/10.3390/v11080732

  • Rai, M., Kon, K., Ingle, A., Duran, N., Galdiero, S., Galdiero, M.: Broad-spectrum bioactivities of silver nanoparticles: The emerging trends and future prospects. Appl. Microbiol. Biotechnol. 98, 1951–1961 (2014). https://doi.org/10.1007/s00253-013-5473-x

    Article  CAS  Google Scholar 

  • Rogers, J.V., Parkinson, C.V., Choi, Y.W., Speshock, J.L., Hussain, S.M.: A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Res. Lett. 3, 129–133 (2008). https://doi.org/10.1007/s11671-008-9128-2

    Article  CAS  Google Scholar 

  • Shady, N.H., Khattab, A.R., Ahmed, S., Liu, M., Quinn, R.J., Fouad, M.A., Kamel, M.S., Muhsinah, A.B., Krischke, M., Mueller, M.J., Abdelmohsen, U.R.: Hepatitis C virus NS3 protease and helicase inhibitors from red sea sponge (Amphimedon) species in green synthesized silver nanoparticles assisted by in silico modeling and metabolic profiling. Int. J. Nanomedicine 15, 3377–3389 (2020). https://doi.org/10.2147/IJN.S233766

  • Sharma, R.K., Cwiklinski, K., Aalinkeel, R., Reynolds, J.L., Sykes, D.E., Quaye, E., Oh, J., Mahajan, S.D., Schwartz, S.A.: Immunomodulatory activities of curcumin-stabilized silver nanoparticles: Efficacy as an antiretroviral therapeutic. Immunol. Invest. 46, 833–846 (2017). https://doi.org/10.1080/08820139.2017.1371908

    Article  CAS  Google Scholar 

  • Speshock, J.L., Murdock, R.C., Braydich-Stolle, L.K., Schrand, A.M., Hussain, S.M.: Interaction of silver nanoparticles with Tacaribe virus. J. Nanobiotechnology 8, 1–9 (2010). https://doi.org/10.1186/1477-3155-8-19

  • Sun, R.W.Y., Chen, R., Chung, N.P.Y., Ho, C.M., Lin, C.L.S., Che, C.M.: Silver nanoparticles fabricated in Hepes buffer exhibit cytoprotective activities toward HIV-1 infected cells. Chem. Commun. 5059–5061 (2005). https://doi.org/10.1039/b510984a

  • Sun, L., Singh, A., Vig, K., Pillai, S.R., Singh, S.R.: Silver Nanoparticles Inhibit Replication of Respiratory Syntical Virus. J. Biomed. Nanotechnol 4, 149–158 (2008)

    Google Scholar 

  • Tsai, C.H., Whiteley, C.G., Lee, D.J.: Interactions between HIV-1 protease, silver nanoparticles, and specific peptides. J. Taiwan Inst. Chem. Eng. 103, 20–32 (2019). https://doi.org/10.1016/j.jtice.2019.07.019

    Article  CAS  Google Scholar 

  • Whiteley, C.G., Shing, C.Y., Kuo, C.C., Lee, D.J.: Docking of HIV protease to silver nanoparticles. J. Taiwan Inst. Chem. Eng. 60, 83–91 (2016). https://doi.org/10.1016/j.jtice.2015.10.029

    Article  CAS  Google Scholar 

  • WHO: COVID-19 vaccine development, Coronavirus Update 37 (2020)

    Google Scholar 

  • Xiang, D.X., Chen, Q., Pang, L., Zheng, C.L.: Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. J. Virol. Methods 178, 137–142 (2011). https://doi.org/10.1016/j.jviromet.2011.09.003

  • Xiang, D., Zheng, Y., Duan, W., Li, X., Yin, J., Shigdar, S., O’Connor, M.L., Marappan, M., Zhao, X., Miao, Y., Xiang, B., Zheng, C.: Inhibition of A/Human/Hubei/3/2005 (H3N2) influenza virus infection by silver nanoparticles in vitro and in vivo. Int. J. Nanomedicine 8, 4103–4114 (2013). https://doi.org/10.2147/IJN.S53

    Article  Google Scholar 

  • Yang, X.X., Li, C.M., Huang, C.Z.: Curcumin modified silver nanoparticles for highly efficient inhibition of respiratory syncytial virus infection. Nanoscale 8, 3040–3048 (2016). https://doi.org/10.1039/c5nr07918g

    Article  CAS  Google Scholar 

  • Zoulim, F.: Mechanism of viral persistence and resistance to nucleoside and nucleotide analogs in chronic Hepatitis B virus infection. Antiviral Res. 64, 1–15 (2004). https://doi.org/10.1016/j.antiviral.2004.07.003

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiran Mayookh Lal .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lal, H.M., Uthaman, A., Thomas, S. (2021). Silver Nanoparticle as an Effective Antiviral Agent. In: Lal, H.M., Thomas, S., Li, T., Maria, H.J. (eds) Polymer Nanocomposites Based on Silver Nanoparticles. Engineering Materials. Springer, Cham. https://doi.org/10.1007/978-3-030-44259-0_10

Download citation

Publish with us

Policies and ethics